VINCENZO ROCHIRA
Ricercatore Universitario Confermato SSD MED/50
Endocrinologia, Centro Nalin , Largo del Pozzo 71 Modena
IGIENE DENTALE
Breve Curriculum Vitae
Laurea in Medicina e Chirurgia nel 1994 presso l’Università di Modena, specializzazione in Endocrinologia e Malattie del Ricambio presso l'Universita' di Modena nel 1999, Dottorato
di Ricerca in Scienze Endocrino-Metaboliche nel 2004. Ricercatore Universitario presso la Facoltà Medicina e Chirurgia dell'Universita' di Modena
Pubblicazioni più recenti Autore di circa 40 pubblicazioni in extenso su riviste internazionali indicizzate e circa 200 pubblicazioni compresi gli atti di congressi e l’attività editoriale e trattatistica.
1. Lo Re V 3rd, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V,
Kostman JR, Tebas P. Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS. 2009 Sep 23. [Epub ahead of print]
2. Rochira V, Carani C. Aromatase deficiency in men: a clinical perspective. Nat Rev
3. Zirilli L, Maffei L, Meunier PJ, Chavassieux P, Carani C, Rochira V. The effects of long-
term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency. Bone. 2009 45:827-32.
4. Luzi K, Guaraldi G, Murri R, De Paola M, Orlando G, Squillace N, Esposito R, Rochira V,
Zirilli L, Martinez E. Body image is a major determinant of sexual dysfunction in stable HIV-infected women. Antivir Ther. 2009;14: 85-92.
5. Zirilli L, Benatti P, Romano S, Roncucci L, Rossi G, Diazzi C, Carani C, Ponz De Leon M,
Rochira V. Differentiated thyroid carcinoma (DTC) in a young woman with Peutz-Jeghers syndrome: are these two conditions associated? Exp Clin Endocrinol Diabetes. 2009 117:234-9.
6. Rochira V, Zirilli L, Madeo B, Maffei L, Carani C. Testosterone action on erythropoiesis
does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men. J Steroid Biochem Mol Biol. 2009 113:189-94.
7. Zirilli L, Orlando G, Diazzi C, Squillace N, Carani C, Guaraldi G, Rochira V.
Hypopituitarism and HIV-infection: a new comorbidity in the HAART era? J Endocrinol Invest. 2008 31:33-8.
8. Salmaggi A, Zirilli L, Pantaleoni C, De Joanna G, Del Sorbo F, Koehler K, Krumbholz M,
Huebner A, Rochira V. Late-onset triple A syndrome: a risk of overlooked or delayed diagnosis and management. Horm Res. 2008;70:364-72.
9. Balestrieri A, Zirilli L, Madeo B, Pignatti E, Rossi G, Carani C, Rochira V. 21-hydroxylase
deficiency and klinefelter syndrome in an adult man: striking a balance between androgen excess and insufficiency. J Androl. 2008 29:605-9.
10. Lanfranco F, Zirilli L, Baldi M, Pignatti E, Corneli G, Ghigo E, Aimaretti G, Carani C,
Rochira V. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone. 2008 Sep;43(3):628-35.
11. Zirilli L, Rochira V, Diazzi C, Caffagni G, Carani C. Human models of aromatase
deficiency. J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):212-8.
12. Madeo B, Bettica P, Milleri S, Balestrieri A, Granata AR, Carani C, Rochira V. The effects
of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. J Sex Med. 2008 Oct;5(10):2431-41.
RASSEGNA STAMPA FALCRI 10 MARZO 2009 A cura di Manlio Lo Presti ESERGO Il solo, il vero programma di ogni italiano è di essere in buoni rapporti con il partito al potere. C. MALAPARTE, Deux chapeaux de paille de l’Italie Disoccupati, allarme della Ue Borse europee contrastate Allarme Ue. Una «recessione senza precedenti che potrebbe causare altri 6 milioni di
ABORTION WITH SELF-ADMINISTERED MISOPROSTOL: INTRODUCTION Millions of women worldwide have safely terminated their pregnancies with medication since mifepristone — or RU 486—was first introduced in the late 1980s. Research in the past two decades has identified several highly effective regimens for early medical abortion with a success rate of 95 to 98 percent, consisting of 200 mg of mif